Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1940272 AUSTIN, TX
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$465,465
-$11,154 QoQ
Shares Held
42,900
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#84
of 161 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Derivatives in PHAT

reported options exposure · as of Mar 31, 2025
CallValue
$63,327
CallShares
10,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. PHAT ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in PHAT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $465,465 42,900
2026-03-31 $476,619 42,900
2025-12-31 $711,711 42,900
2025-09-30 $504,933 42,900
2025-06-30 $608,236 63,424
2025-03-31 $268,356 42,800
2025-03-31 $63,327 10,100
2024-12-31 $82,012 10,100
2024-12-31 $449,848 55,400
2024-09-30 $3,616 200